IP Library Granted Patent US 7,923,545
Granted Patent B2
US 7,923,545 · App. 12/491,487 · Granted Apr 12, 2011

Caterpiller gene family

Assignee: The University of North Carolina at Chapel Hill
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,923,545
App. No.
12/491,487
Granted
Apr 12, 2011
Kind
B2
Abstract

The present invention relates to a new family of structurally and functionally related nucleic acids and proteins, designed the CATERPILLER family, which is characterized by landmark structural motifs including a nucleotide binding domain and leucine-rich repeat domains.

Claims (16)

1. An isolated nucleic acid encoding a CATERPILLER 16.2 polypeptide comprising a nucleotide sequence selected from the group consisting of:

(a) the nucleotide sequence of SEQ ID NO:27;

(b) a nucleotide sequence that encodes a polypeptide having the amino acid sequence of SEQ ID NO:28; and

(c) a nucleotide sequence that differs from the nucleotide sequences of (a), (b) or (c) above due to the degeneracy of the genetic code.

2. An isolated cell comprising the isolated nucleic acid of claim 1 .

3. A method of identifying a compound that binds to a CATERPILLER 16.2 polypeptide encoded by the nucleic acid of claim 1 comprising:

contacting the polypeptide with a test compound under conditions whereby binding between the polypeptide and the test compound can be detected; and

detecting binding between the polypeptide and the test compound.

4. A method of identifying a compound that modulates the activity of a CATERPILLER 16.2 polypeptide encoded by the nucleic acid of claim 1 comprising:

contacting the polypeptide with a test compound under conditions whereby modulation of the activity of the polypeptide can be detected; and

detecting modulation of the activity of the polypeptide.

5. The method of claim 3 , wherein the method is carried out in a cell comprising the polypeptide.

6. The method of claim 5 , wherein the cell comprises an isolated nucleic acid comprising a nucleotide sequence encoding the polypeptide.

7. The method of claim 6 , wherein the cell is stably transformed with the isolated nucleic acid.

8. The method of claim 3 , wherein the method is carried out as a cell-free assay.

9. The method of claim 3 , wherein the method is carried out in a transgenic non-human mammal comprising an isolated nucleic acid comprising a nucleotide sequence encoding the polypeptide.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jan 30, 2017
From: UNIV OF NORTH CAROLINA CHAPEL HILL
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 041548/0842 →
CONFIRMATORY LICENSE Recorded Jan 27, 2017
From: THE UNIVERISTY OF NORTH CAROLINA AT CHAPEL HILL
To: NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR
Reel/Frame 041536/0465 →
Continuity (3)
Division 10511989
Provisional Application 60376626 · Apr 30, 2002
Related Publication 20090291450A1 · Nov 26, 2009